Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 1—January 2022
Letter

New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria

Cite This Article

To the Editor: Findlay et al. (1) reported a high prevalence (>25%) of New Delhi metallo-β-lactamase (NDM) among carbapenemase-producing Enterobacterales (CPE) in Switzerland during 2019–2020. To provide context, we analyzed recent trends for NDM-producers in Germany.

In a whole-genome-sequencing–based surveillance study conducted in 52 hospitals in Hesse, Germany, during 2017–2019, we detected 56 NDM-producing isolates among 346 CPE. The prevalence of NDM CPE increased from 6.3% (5/79) in 2017 to 15.0% (17/113) in 2018 and 22.1% (34/154) in 2019. A total of 56 alleles—28 NDM-1, 27 NDM-5, and 1 NDM-7—were detected in 31 Klebsiella pneumoniae, 18 Escherichia coli, and 3 Citrobacter freundii isolates and 1 isolate each of C. portucalensis, Enterobacter hormaechei, K. grimontii, and K. variicola. Isolates were derived from rectal swab (30), urine (11), respiratory tract (6), and other (9) specimens. More than 82% (23/28) of NDM-1 were associated with K. pneumoniae and 59% (16/27) of NDM-5 with E. coli; 41% of the NDM-CPE harbored a 16S-rRNA-methylase gene.

Among carbapenemase-producing K. pneumoniae isolates, NDM increased from 6.4% (3/47) in 2017 to 24.5% (13/53) in 2018 and 31.9% (15/47) in 2019; ≈50% (15/31) were sequence type 147. Thus, reports for Switzerland (1) and Italy (2) indicate that sequence type 147 NDM-carrying K. pneumoniae is a CPE clone rapidly emerging in Europe.

NDM accounted for 20% (2/10) of carbapenemase-producing E. coli in 2017, 11.1% (2/18) in 2018, and 24.1% (14/58) in 2019; the increase in NDM-5–producing E. coli was primarily associated with IncF-type plasmids (3). A subgroup harboring penicillin binding protein 3 modifications exhibited increased aztreonam/avibactam MICs of 2–8 μg/mL. Higher MICs (4–16 μg/mL) were associated with the presence of an additional highly conserved blaCMY-42–encoding IncIγ plasmid (4). We reiterate the call by Findlay et al. to implement genome-based surveillance studies to identify emerging clonal lineages and commonly occurring plasmids among carbapenemase-producing bacteria.

Top

Acknowledgment

We thank members of the SurvCARE Hesse Working Group who contributed data or sample collection or both: Eugen Domann, Jane Falgenhauer, and Moritz Fritzenwanker (Justus Liebig University, Giessen, Germany); Petra Heinmüller and Gudrun Bettge-Weller (Hessisches Landesprüfungs und Untersuchungsamt im Gesundheitswesen, Dillenburg, Germany); and Anja M. Hauri (Helmholtz Centre for Infection Research, Braunschweig, Germany).

Top

Yancheng Yao, Can Imirzalioglu, Linda Falgenhauer, Trinad ChakrabortyComments to Author , and SurvCARE Hesse Working Group
Author affiliation: Justus Liebig University German Center for Infection Research, Giessen, Germany.

Top

References

  1. Findlay  J, Poirel  L, Kessler  J, Kronenberg  A, Nordmann  P. New Delhi metallo-β-lactamase-producing Enterobacterales bacteria, Switzerland, 2019-2020. Emerg Infect Dis. 2021;27:262837. DOIPubMedGoogle Scholar
  2. Tavoschi  L, Forni  S, Porretta  A, Righi  L, Pieralli  F, Menichetti  F, et al. Prolonged outbreak of New Delhi metallo-betalactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE), Tuscany, Italy, 2018 to 2019. Vol. 25, Eurosurveillance. European Centre for Disease Prevention and Control (ECDC); 2020.
  3. Chakraborty  T, Sadek  M, Yao  Y, Imirzalioglu  C, Stephan  R, Poirel  L, et al. Cross-border emergence of Escherichia coli producing the carbapenemase NDM-5 in Switzerland and Germany. J Clin Microbiol. 2021;59:e0223820. DOIPubMedGoogle Scholar
  4. Nordmann  P, Yao  Y, Falgenhauer  L, Sadek  M, Imirzalioglu  C, Chakraborty  T. Recent emergence of aztreonam-avibactam resistance in NDM and OXA-48 carbapenemase-producing Escherichia coli in Germany. Antimicrob Agents Chemother. 2021;65:e0109021. DOIPubMedGoogle Scholar

Top

Cite This Article

DOI: 10.3201/eid2801.212106

Related Links

Top

Table of Contents – Volume 28, Number 1—January 2022

EID Search Options
presentation_01 Advanced Article Search – Search articles by author and/or keyword.
presentation_01 Articles by Country Search – Search articles by the topic country.
presentation_01 Article Type Search – Search articles by article type and issue.

Top

Comments

Please use the form below to submit correspondence to the authors or contact them at the following address:

Trinad Chakraborty, Institute of Medical Microbiology, Justus Liebig University Giessen, Schubertstrasse 81, D-35392 Giessen, Germany

Send To

10000 character(s) remaining.

Top

Page created: December 20, 2021
Page updated: December 20, 2021
Page reviewed: December 20, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external